Vincerx Pharma, Inc. (VINC)
NASDAQ: VINC · Real-Time Price · USD
0.709
+0.019 (2.80%)
Sep 12, 2024, 4:00 PM EDT - Market closed
Vincerx Pharma Employees
Vincerx Pharma had 42 employees as of December 31, 2023. The number of employees increased by 1 or 2.44% compared to the previous year.
Employees
42
Change (1Y)
1
Growth (1Y)
2.44%
Revenue / Employee
n/a
Profits / Employee
-$671,286
Market Cap
21.90M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 42 | 1 | 2.44% |
| Dec 31, 2022 | 41 | -15 | -26.79% |
| Dec 31, 2021 | 56 | 28 | 100.00% |
| Dec 31, 2020 | 28 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Neuronetics | 203 |
| BioXcel Therapeutics | 74 |
| NKGen Biotech | 63 |
| Pieris Pharmaceuticals | 50 |
| HCW Biologics | 45 |
| Acasti Pharma | 32 |
| Brainstorm Cell Therapeutics | 29 |
| Lipocine | 17 |
VINC News
- 5 weeks ago - Vincerx Pharma Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 months ago - Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants - GlobeNewsWire
- 5 months ago - Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants - GlobeNewsWire
- 5 months ago - Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024 - GlobeNewsWire
- 5 months ago - Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update - GlobeNewsWire
- 6 months ago - Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024 - GlobeNewsWire
- 8 months ago - Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma - GlobeNewsWire